CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Polymyalgia rheumatica - Management
Basis for recommendation
- These referral recommendations are based on published guidelines [Dasgupta et al, 2007], which are based on draft guidelines from the British Society for Rheumatology.
- Many conditions can mimic polymyalgia rheumatica, and it is generally recommended that people with suspected polymyalgia rheumatica should obtain at least one rheumatology opinion.
- Treatment with corticosteroids can be started while the person is waiting to be seen by a specialist.
- People with typical features of polymyalgia rheumatica who show a complete sustained response to corticosteroids may then be managed in primary care.
© NHS Institute for Innovation and Improvement